Prevalence and Mechanisms of Malnutrition in Patients With Advanced Liver Disease, and Nutrition Management Strategies

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 2, 2012, Pages 117-125

  Cheung, Kally ^a   Lee, Samuel S ^b   Raman, Maitreyi ^b  

^a ALBERTA HEALTH SERVICES   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cirrhosis; Diet; Liver Disease; Malnutrition; Nutrient Therapies

Indexed keywords

ALPHA TOCOPHEROL; AROMATIC CARBOXYLIC ACID; BRANCHED CHAIN AMINO ACID; CYTOKINE; FOLIC ACID; GHRELIN; GLUCOSE; INSULIN; LACTALBUMIN; MALTODEXTRIN; PROBIOTIC AGENT; RETINOL; SELENIUM; SODIUM; THIAMINE; VITAMIN D; VITAMIN K GROUP; ZINC;

ALCOHOL ABUSE; ANOREXIA; ASCITES; CONTINUING EDUCATION; CYTOKINE PRODUCTION; DECOMPENSATED LIVER CIRRHOSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; GLUCOSE METABOLISM; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HUMAN; HYPERMETABOLISM; INSULIN RESISTANCE; LIVER CIRRHOSIS; MALABSORPTION; MALNUTRITION; MEDICAL EDUCATION; MORBIDITY; MORTALITY; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PREVALENCE; PROTEIN DEGRADATION; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINOL DEFICIENCY; REVIEW; SODIUM RESTRICTION; VITAMIN D DEFICIENCY;

DIET; HUMANS; LIVER CIRRHOSIS; MALNUTRITION; PREVALENCE; TREATMENT OUTCOME;

EID: 84856054318     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.08.016     Document Type: Review

References (82)

1. Merli M., Riggio O., Dally L. Does malnutrition affect survival in cirrhosis?. PINC (Policentrica Italiana Nutrizione Cirrosi). Hepatology 1996, 23:1041-1046.
2. Tsiaousi E.T., Hatzitolios A.I., Trygonis S.K., et al. Malnutrition in end stage liver disease: recommendation and nutritional support. J Gastroenterol Hepatol 2008, 23:527-533.
3. Hirsch S., de la Maza M.P., Gattás V., et al. Nutritional support in alcoholic cirrhotic patients improves host defenses. J Am Coll Nutr 1999, 18:434-441.
4. Tai M.L., Goh K.L., Mohd-Taib S.H., et al. Anthropometric, biochemical and clinical assessment of malnutrition in Malaysian patients with advanced cirrhosis. Nutr J 2010, 9:27.
5. Jensen G.L., Mirtallo J., Compher C., et al. Adult starvation and disease-related malnutrition: a proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee. JPEN J Parenter Enteral Nutr 2010, 34:156-159.
6. Stephenson G.R., Moretti E.W., EL-Moalem H., et al. Malnutrition in liver transplant patients: preoperative subjective global assessment is predictive of outcome after liver transplantation. Transplantation 2001, 72:666-670.
7. Carvalho L., Parise E.R. Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis. Arq Gastroenterol 2006, 43:269-274.
8. Merli M., Giusto M., Gentili F., et al. Nutritional status: its influence on the outcome of patients undergoing liver transplantation. Liver Int 2010, 30:208-214.
9. Kalaitzakis E., Simrén M., Olsson R., et al. Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life. Scand J Gastroenterol 2006, 41:1464-1472.
10. Qin H., Li H., Xing M., et al. Nutritional support treatment for severe chronic hepatitis and posthepatitic cirrhosis. J Huazhong Univ Sci Technolog Med Sci 2006, 26:217-220.
11. Nutritional Status in Cirrhosis. Italian multicentre cooperative project on nutrition in liver cirrhosis. J Hepatol 1994, 21:317-325. Anonymous.
12. Sam J., Nguyen G.C. Protein-calorie malnutrition as a prognostic indicator of mortality among patients hospitalized with cirrhosis and portal hypertension. Liver Int 2009, 29:1396-1402.
13. Alvares-da-Silva M.R., Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition 2005, 21:113-117.
14. Mahan L.K., Escott-stump S. Krauses's food nutrition and diet therapy 2000, WB Saunders Company, Philipdelphia, PA. 10th ed.
15. Müller M.J., Böttcher J., Selberg O., et al. Hypermetabolism in clinically stable patients with liver cirrhosis. Am J Clin Nutr 1999, 69:1194-1201.
16. Peng S., Plank L.D., McCall J.L., et al. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr 2007, 85:1257-1266.
17. Dolz C., Ravrich J.M., Ibanez J., et al. Ascites increases the resting energy expenditure in liver cirrhosis. Gastroenterology 1991, 100:738.
18. Chen W.J., Chung Y.C. Energy expenditure in patients with hepatocellular carcinoma. Cancer 1994, 73:590-595.
19. Braillon A., Gaudin C., Poo J.L., et al. Plasma catecholamine concentrations are a reliable index of sympathetic vascular tone in patients with cirrhosis. Hepatology 1992, 15:58-62.
20. Braillon A., Cales P., Valla D., et al. Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut 1986, 27:1204-1209.
21. Lee S.S., Baik S.K. Clinical consequences of cirrhosis: cardiovascular. Zakim and Boyer's hepatology 2006, 457-475. Saunders Elsevier, Philadephia. 5th ed. T.D. Boyer, T.L. Wright, M.P. Manns (Eds.).
22. Ruiz-del-Arbol L., Urman J., Fernández J., et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003, 38:1210-1218.
23. Dudrick S.J., Kavic S.M. Hepatobiliary nutrition: history and future. J Hepato Biliary Pancreat Surg 2002, 9:459-468.
24. Pace A., de Weerth A., Berna M., et al. Pancreas and liver injury are associated in individuals with increased alcohol consumption. Clin Gastroenterol Hepatol 2009, 7:1241-1246.
25. Badley B.W.D., Murphy F.M., Bouchier I.A.D., et al. Diminishede micellular phase lipid in patients with chronic non-alcoholic liver disease and steatorrhea. Gastroenterology 1970, 58:781-789.
26. Cabre E., Hernandez-Perez J.M., Fluvia L., et al. Absorption and transport of dietary long-chain fatty acids in cirrhosis: a stable-isotope-tracing study. Am J Clin Nutr 2005, 81:692-701.
27. Pignon J.P., Baraona E., Poynard T., et al. Serum lipoproteins and alcoholic diseases of the liver [in French]. Gastroenterol Clin Biol 1987, 11:460-472.
28. Santos M., Friedberg S.J., Kudzma D.J., et al. Conversion of free fatty acids to triglycerides. Determination in obstructive vs hepatocellular jaundice and cirrhosis. Arch Intern Med 1974, 134:457-460.
29. Bugianesi E., Kalhan S., Burkett E., et al. Quantification of gluconeogenesis in cirrhosis: response to glucagon. Gastroenterologist 1998, 115:1530-1540.
30. Changani K.K., Jalan R., Cox I.J., et al. Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy. Gut 2001, 49:557-564.
31. Owen O.E., Reichle F.A., Mozzoli M.A., et al. Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis. J Clin Invest 1981, 68:240-252.
32. Kalaitzakis E., Bosaeus I., Ohman L., et al. Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure. Am J Clin Nutr 2007, 85:808-815.
33. Merli M., Leonetti F., Riggio O., et al. Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation. Hepatology 1999, 30:649-654.
34. Müller M.J., Lautz H.U., Plogmann B., et al. Energy expenditure and substrate oxidation in patients with cirrhosis: the impact of cause, clinical staging and nutritional state. Hepatology 1992, 15:782-794.
35. Aqel B.A., Scolapio J.S., Dickson R.C., et al. Contribution of ascites to impaired gastric function and nutritional intake in patients with cirrhosis and ascites. Clin Gastroenterol Hepatol 2005, 3:1095-1100.
36. Mccullough A.J., Bugianesi E., Marchesini G., et al. Gender dependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology 1998, 119:947-953.
37. Le Moine O., Marchant A., De Groote D., et al. Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis. Hepatology 1995, 22:1436-1439.
38. Grossberg A.J., Scarlett J.M., Marks D.L. Hypothalamic mechanisms in cachexia. Physiol Behav 2010, 100:478-489.
39. Ockenga J., Bischoff S.C., Tillmann H.L., et al. Elevated bound leptin correlates with energy expenditure in cirrhotics. Gastroenterology 2001, 119:1656-1662.
40. Marchesini G., Bianchi G., Lucidi P., et al. Plasma ghrelin concentrations, food intake, and anorexia in liver failure. J Clin Endocrinol Metab 2004, 89:2136-2141.
41. Sturniolo G.C., D'Incà R., Parisi G., et al. Taste alterations in liver cirrhosis: are they related to zinc deficiency?. J Trace Elem Electrolytes Health Dis 1992, 6:15-19.
42. Madden A.M., Bradbury W., Morgan M.Y. Taste perception in cirrhosis: its relationship to circulating micronutrients and food preferences. Hepatology 1997, 26:40-48.
43. de la Vega M.J., Santolaria F., González-Reimers E., et al. High prevalence of hyperhomocysteinemia in chronic alcoholism: the importance of the thermolabile form of the enzyme methylenetetrahydrofolate reductase (MTHFR). Alcohol 2001, 25:59-67.
44. Bergheim I., Parlesak A., Dierks C., et al. Nutritional deficiencies in German middle-class male alcohol consumers: relation to dietary intake and severity of liver disease. Eur J Clin Nutr 2003, 57:431-438.
45. Levine J.A., Morgan M.Y. Weighed dietary intakes in patients with chronic liver disease. Nutrition 1996, 12:430-435.
46. Yoshida Y., Higashi T., Nouso K., et al. Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis. Acta Med Okayama 2001, 55:349-355.
47. Phillips J.R., Angulo P., Petterson T., et al. Fat-soluble vitamin levels in patients with primary biliary cirrhosis. Am J Gastroenterol 2001, 96:2745-2750.
48. Arteh J., Narra S., Nair S. Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci 2010, 55:2624-2628.
49. Lindor K.D., Gershwin M.E., Poupon R., et al. Primary biliary cirrhosis. Hepatology 2009, 50:291-308.
50. Lin C.C., Yin M.C. Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin. Clin Nutr 2009, 28:34-38.
51. Plauth M., Cabré E., Riggio O., et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr 2006, 25:285-294.
52. Figueiredo F.A., Perez R.M., Freitas M.M., et al. Comparison of three methods of nutritional assessment in liver cirrhosis: subjective global assessment, traditional nutritional parameters, and body composition analysis. J Gastroenterol 2006, 41:476-482.
53. Taniguchi E., Kawaguchi T., Itou M., et al. Subjective global assessment is not sufficient to screen patients with defective hepatic metabolism. Nutrition 2011, 27:282-286.
54. Morgan M.Y., Madden A.M., Soulsby C.T., et al. Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis. Hepatology 2006, 44:823-835.
55. Nishida T., Tsuji S., Tsujii M., et al. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol 2006, 101:70-75.
56. Delich P.C., Siepler J.K., Parker P. Liver disease. The A.S.P.E.N. nutrition support core curriculum: a case based approach-the adult patient 2007, 540-557. American Society for Parenteral and Enternal Nutrition, Silver Spring, MD. M.M. Gottschlich (Ed.).
57. Nakaya Y., Okita K., Suzuki K., et al. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007, 23:113-120.
58. Matsumoto D., Yamanaka-Okumura H., Arai H., et al. Nutritional treatment of a patient with hepatic cirrhosis with the novel low glycemic index liquid food (Inslow). J Med Invest 2007, 54:375-380.
59. Barkoukis H., Fiedler K.M., Lerner E. A combined high fiber, low glycemic index diet normalizes glucose tolerance and reduces hyperglycemia and hyperinsulinemia in adults with hepatic cirrhosis. J Am Diet Assoc 2002, 102:1503-1507.
60. Jenkins D.J., Shapira N., Greenberg G., et al. Low glycemic index foods and reduced glucose, amino acid, and endocrine responses in cirrhosis. Am J Gastroenterol 1989, 84:732-739.
61. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids 2005, Institute of Medicine, National Academies Press, Washington, DC.
62. Schulz G.J., Campos A.C., Coelho J.C. The role of nutrition in hepatic encephalopathy. Curr Opin Clin Nutr Metab Care 2008, 11:275-280.
63. Córdoba J., López-Hellín J., Planas M., et al. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol 2004, 41:38-43.
64. Sokol R.J. Fat-soluble vitamins and their importance in patients with cholestatic liver diseases. Gastroenterol Clin North Am 1994, 23:673-705.
65. Moore K.P., Aithal G.P. Guidelines on the management of ascites in cirrhosis. Gut 2006, 55:1-12.
66. Salerno F., Guevara M., Bernardi M., et al. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis. Liver Int 2010, 30:937-947.
67. Gupta A., Dhiman R.K., Kumari S., et al. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol 2010, 53:849-855.
68. Malaguarnera M., Gargante M.P., Malaguarnera G., et al. Bifidobacterium combined with fructo-oligosaccharide versus lactulosei n the treatment of patients with hepatic encephalopathy. Eur J Gastroenterol Hepatol 2010, 22:199-206.
69. Malaguarnera M., Greco F., Barone G., et al. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci 2007, 52:3259-3265.
70. Sharma P., Sharma B.C., Sarin S.K. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis. Liver Int 2009, 29:1365-1371.
71. Pereg D., Kotliroff A., Gadoth N., et al. Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study. Nutrition 2011, 27:177-181.
72. Bajaj J.S., Saeian K., Christensen K.M., et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 2008, 103:1707-1715.
73. Liu Q., Duan Z.P., Ha D.K., et al. Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004, 39:1441-1449.
74. Lam V., Poon R. Role of branched chain amino acids in management of cirrhosis and hepatocellular carcinoma. Hepatol Res 2008, 38(Suppl 1):107-115.
75. James J.H., Ziparo V., Jeppsson B., et al. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet 1979, 2:772-775.
76. Chadalavada R., Sappati Biyyani R.S., Maxwell J., et al. Nutrition in Hepatic encephalopathy. Nutr Clin Pract 2010, 25:257-264.
77. Marchesini G., Bianchi G., Merli M., et al. Nutritional supplementation with branched-chain amino acid in advanced cirrhosis: a double blind, randomized trial. Gastroenterology 2003, 124:1792-1801.
78. Muto Y., Sato S., Watanabe A., et al. Effects of oral branched chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 2005, 3:705-713.
79. Charlton M. Branched-chain amino acids: metabolism, physiological function, and application. J Nutr 2006, 136:295S-298S.
80. Plank L.D., Gane E.J., Peng S., et al. Noctural nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial. Hepatology 2008, 48:557-566.
81. Wicks C., Somasundaram S., Bjarnason I., et al. Comparison of enteral feeding and total parenteral nutrition after liver transplantation. Lancet 1994, 344:837-840.
82. Plauth M., Cabré E., Campillo B., et al. ESPEN Guidelines on Parenteral Nutrition: hepatology. Clin Nutr 2009, 28:436-444.